Literature DB >> 16985575

Endothelin-a receptor antagonists and advanced prostate cancer.

Masood A Khan, Alan W Partin.   

Abstract

Entities:  

Year:  2004        PMID： 16985575      PMCID： PMC1472675     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  9 in total

1.  The endothelin family: an overview.

Authors:  T Masaki
Journal:  J Cardiovasc Pharmacol       Date:  2000       Impact factor: 3.105

2.  New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade.

Authors:  J B Nelson; S H Nguyen; J R Wu-Wong; T J Opgenorth; D B Dixon; L W Chung; N Inoue
Journal:  Urology       Date:  1999-05       Impact factor: 2.649

3.  The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae.

Authors:  Y Takuwa; T Masaki; K Yamashita
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

4.  Methylation of the neutral endopeptidase gene promoter in human prostate cancers.

Authors:  B A Usmani; R Shen; M Janeczko; C N Papandreou; W H Lee; W G Nelson; J B Nelson; D M Nanus
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

5.  Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial.

Authors:  Michael A Carducci; Robert J Padley; Jurgen Breul; Nicholas J Vogelzang; Bernard A Zonnenberg; Danai D Daliani; Claude C Schulman; Azmi A Nabulsi; Rod A Humerickhouse; Mark A Weinberg; Jennifer L Schmitt; Joel B Nelson
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

6.  Expression of endothelin receptor a associated with prostate cancer progression.

Authors:  K Gohji; S Kitazawa; H Tamada; Y Katsuoka; M Nakajima
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

7.  Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies.

Authors:  P Langenstroer; R Tang; E Shapiro; B Divish; T Opgenorth; H Lepor
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

8.  Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.

Authors:  J B Nelson; S P Hedican; D J George; A H Reddi; S Piantadosi; M A Eisenberger; J W Simons
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

9.  Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.

Authors:  J B Nelson; K Chan-Tack; S P Hedican; S R Magnuson; T J Opgenorth; G S Bova; J W Simons
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701
  9 in total
  1 in total

Review 1.  From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors.

Authors:  Oana Draghiciu; Hans W Nijman; Toos Daemen
Journal:  Clin Dev Immunol       Date:  2011-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.